CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Fundação Pio XII (FP). Hospital do Câncer de Barretos (Institutional affiliation from the last research proposal) Birthplace: Portugal
Scientific Director of the Teaching and Research Institute (IEP); Coordinator of the Molecular Oncology Research Center (CPOM); and Scientific Director of the Molecular Diagnostic Laboratory at the Barretos Cancer Hospital, Barretos, SP. Brazil. Invited Associate Professor at the University of Minho School of Medicine (Braga, Portugal). Extraordinary Professor, Pan African Cancer Research Institute, University of Pretoria, South Africa. Graduation in biology, University of Porto (Portuga) l; doctorate in neuro-oncology, IARC (Lyon, France); postdoctoral fellow in cancer genomics, Free University Medical Center (Amsterdam, Netherlands) and IPATIMUP (Porto, Portugal). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Prostate cancer is the second leading cause of male cancer mortality in Brazil. In recent years, prostate-specific membrane antigen (PSMA)-targeted radioligand therapy has emerged as a promising option for patients suffering from mCRPC and do not respond to previously recommended therapies. Indeed, 45-60% of patients with mCRPC respond to 177Lu-PSMA therapy as demonstrated by several clin…
The Molecular Oncology Research center (CPOM) was officially opened in August 2010. The creation of this laboratory sought to meet the most demanding quality criteria, and the design of the project was made based on the most modern research centers, emphasizing the practicality of circulation, the ease of access to technological resources and the supervision of trained professionals.In Au…
(Only some records are available in English at this moment)
Colorectal cancer (CCR) is the third most common type of cancer in the world, and in Brazil, it is the second most incident and despite early screening and new treatment strategies, it remains the second most fatal cancer in the world. The intestinal microbiota has been implicated in the development of colorectal cancer. The work of our group has identified the pathogenic role of Fusobact…
Glioblastoma (GBM) is the most common primary intracranial malignant tumor in adults. GBM is extremely invasive and aggressive, accounting for the majority of the 200,000 central nervous system (CNS) tumor-related deaths worldwide each year. GBM in children is relatively rare, with distinct molecular characteristics and response to treatment, when compared to adults. The current standard …
Glioblastoma (GBM) is one of the most common neoplasia of the central nervous system, is characterized as a highly aggressive and invasive tumor, is related to high mortality rates and a poor prognosis. Currently, the standard treatment of this disease consists of surgical removal of the tumor, followed by chemotherapy associated with the use of temozolomide (TMZ), a DNA alkylating agent.…
(Only some records are available in English at this moment)
Colorectal cancer (CRC) is a major global health burden, with high mortality rates due to late-stage diagnosis. Screening programs using fecal occult blood testing and colonoscopy aim to detect precursor lesions and CRC when curative treatment is feasible. However, these methods have limitations, including varying sensitivity and invasiveness. The gut microbiome has emerged as a potential…
High-grade gliomas (HGGs) are aggressive brain tumors characterized by rapid progression and resistance to conventional therapies, resulting in poor patient prognoses. To overcome these challenges, more sophisticated and representative preclinical models are required. This project has two main aims: first, to learn and develop advanced HGG preclinical models such as immunocompetent organo…
Glioblastoma is the most common and aggressive malignant central nervous system (CNS) tumor in adults. The standard protocol is surgery, radiotherapy and adjuvant/comcomitant chemotherapy with temozolomide. The cancer cells usually have resistance mechanisms against this chemotherapy agent, commonly associated with the DNA Repair pathways. To find a way out of this problem, we investiga…
Colorectal cancer (CRC) is the third most common cancer in both males and females and the second and fourth leading cause of cancer-related deaths in both sexes worldwide and in Brazil, respectively. Regarding the treatment of CRC, the current standard of care involves tumor removal through surgery and radiotherapy. Lately, more innovative treatments are proposed, such as targeted therapi…
The gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract whose prognosis of the patients is based on criteria including tumor size, mitotic index and localization. Despite of this classification, GIST progression is often inaccurate. The aim of this study is to elucidate the biological role and therapeutic potential biomarker TERT in…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing grants |
| 11 / 7 | Completed research grants |
| 17 / 16 | Completed scholarships in Brazil |
| 2 / 2 | Ongoing scholarships abroad |
| 4 / 4 | Completed scholarships abroad |
| 35 / 30 | All research grants and scholarships |
| Associated processes | |